Srinivasan Yegnasubramanian

Johns Hopkins University

Full Professor(heuristic)

Prostate Cancer Treatment and Research · Pulmonary and Respiratory Medicine

Compare more Pulmonary and Respiratory Medicine professors.

h-index64
i10-index148
Publications578
Citations16,435

Grants

6 total · 3 active

NIH #P50CA272391

Project 3: Induction of synthetic lethality with combined DNMT and PARP inhibition

Active
Amount
$300K–$400K
Period
2024-09-01 → 2029-08-31
PIs
1

NIH #U54CA274370

Prostate inflammatory lesions as a proving ground for development of aggressive prostate cancer

Active
Amount
$1M–$2M
Period
2022-09-15 → 2027-08-31
PIs
2

NIH #P30CA006973

Experimental and Computational Genomics

Active
Amount
$600K–$700K
Period
1997-05-07 → 2027-05-31
PIs
1

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

6 total · 3 active

NIH #P50CA272391

Project 3: Induction of synthetic lethality with combined DNMT and PARP inhibition

Active
Amount
$300K–$400K
Period
2024-09-01 → 2029-08-31
PIs
1

NIH #U54CA274370

Prostate inflammatory lesions as a proving ground for development of aggressive prostate cancer

Active
Amount
$1M–$2M
Period
2022-09-15 → 2027-08-31
PIs
2

NIH #P30CA006973

Experimental and Computational Genomics

Active
Amount
$600K–$700K
Period
1997-05-07 → 2027-05-31
PIs
1

NIH #R01HL163881

Targeting Estrogenic pathways in Tregs to promote ARDS resolution

Amount
$800K–$900K
Period
2022-06-01 → 2026-05-31
PIs
3

NIH #R01CA183965

Role of TOP2B in generating complex genomic rearrangements in human cancer

Amount
$300K–$400K
Period
2014-04-01 → 2019-02-28
PIs
2

NIH #P50CA058236

Identification and Validation of DNA Methylation Biomarkers for High Grade and/or

Amount
$200K–$300K
Period
— → 2014-08-31
PIs
1

Recent Public Signals

  1. New preprint: Clear cell renal cell carcinoma consensus transcriptomic programs reveal converging trajectories towards aggressive disease2026-06-26
  2. New paper: Structural and cellular insights into DCTPP1 antagonists and their synergistic action with DNMT inhibitors (Proceedings of the National Academy of Sciences)2026-06-15
  3. New NIH award: Project 3: Induction of synthetic lethality with combined DNMT and PARP inhibition2024-09-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-25

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-0744-6606

Professor Insights

Career Trajectory